KORU Medical Systems Signs a Clinical Supply Agreement for Phase 3 Trial with Leading Pharma Partner Using Custom Device for a Novel Subcutaneous Immunoglobulin
Stock Information for KORU Medical Systems Inc.
Loading
Please wait while we load your information from QuoteMedia.